Ultra-high Dose Vitamin D for HSCT

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

May 10, 2020

Study Completion Date

May 10, 2020

Conditions
Hematopoietic Stem Cell Transplant
Interventions
DRUG

Cholecalciferol

A single dose of ultra-high-dose vitamin D (cholecalciferol) will be given prior to hematopoietic stem cell transplant. Research labs including inflammatory biomarker panels will be obtained prior to and after the dose is given.

Trial Locations (1)

90027

Children's Hospital Los Angeles, Los Angeles

All Listed Sponsors
lead

Children's Hospital Los Angeles

OTHER

NCT03759262 - Ultra-high Dose Vitamin D for HSCT | Biotech Hunter | Biotech Hunter